Last reviewed · How we verify
NCT06627296
The Effect of Combined Exercise and NMES on Strength, Proprioception and Reaction Time in Scapholunate Instability
NA trial testing Exercise Training in Scapholunate Interosseous Ligament Injury in 44 participants. Completed in 9 August 2025.
20 December 2024
Quick facts
| Lead sponsor | Hacettepe University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 44 |
| Start date | 8 September 2024 |
| Primary completion | 20 December 2024 |
| Estimated completion | 9 August 2025 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Exercise Training
- Exercise Training (Control Group)
- Neuromuscular Electrical Stimulation
Conditions studied
- Scapholunate Interosseous Ligament Injury — all drugs for Scapholunate Interosseous Ligament Injury →
- Scapholunate Dissociation — all drugs for Scapholunate Dissociation →
- Scaphoid-Lunate Instability — all drugs for Scaphoid-Lunate Instability →
Sponsor
Hacettepe University
Who can join
Adults 18 to 45, any sex, with Scapholunate Interosseous Ligament Injury or Scapholunate Dissociation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In our study, which we conducted to investigate the effect of exercise training combined with neuromuscular electrical stimulation on muscle strength, proprioceptive sensation, reaction time and functionality in patients with scapholunate (SL) instability, individuals with SL instability who meet the inclusion criteria and volunteer to participate in the study will participate. After the approval of the ethics committee, it is planned to include as many individuals with SL instability as the number to be obtained following the power analysis to be performed as a result of the pilot study. The pain of the subjects will be evaluated with the VAS pain scale during rest-activity-exercise. All participants will be evaluated with the isokinetic cybex device for isokinetic muscle strength of the wrist, grip strength with the JAMAR hand held dynometer, NEH evaluation: goniometer, proprioceptive sensation with ACUMAR and isokinetic device, reaction time with blazepod trainer, wrist pain transfer with a digital scale, assessment of upper extremity functional status: pwre (patient rated wrist evaluation), modified mayo wrist score, DASH, EL20 questionnaire, SF-12 questionnaires. In this randomized controlled study, the first group will receive NMES and exercise training 3 days a week for a total of 8 weeks and the other group will receive only exercise training. The evaluations will be done at the beginning and twice in total after the 8-week rehabilitation program. The exercises given to the patients in both groups will be similar for 8 weeks and they will receive a total of 24 sessions of exercise programs with 15 repetitions per day, 3 days a week, accompanied by a physiotherapist. Both groups will also be given home exercises to continue at home. NMES and exercise trainings will be applied in such a way that activation of SL-friendly extensor carpi radialis longus (ECRL), extensor carpi radialis brevis (ECRB), flexor carpi radialis (FCR), and abductor pollicis longus (APL) muscles will be followed by inhibition of non-friendly extensor carpi ulnaris (ECU). After the completion of the thesis, it is planned to add to the literature by examining the effects of exercise training combined with NMES on muscle strength, proprioceptive sensation, reaction time and functionality in individuals diagnosed with SL instability and the superiorities, if any, between the methods.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effectiveness of NMES-integrated therapy in scapholunate ligament injuries - a randomized controlled trial.
Dağ A, Ayık Ö, Fırat T, Şahinkaya T, et al · · 2025 · PMID 41331647 · DOI 10.1186/s13102-025-01452-4
Verify or expand the search:
- PubMed search for NCT06627296
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exercise Training
Trials testing the same drug.
- NCT07384039 — Exercise Training in Patients With Myeloproliferative Neoplasms · NA · not yet recruiting
- NCT07439224 — Qigong and Multicomponent Exercise in Panic Disorder · NA · recruiting
- NCT05797857 — Exercise Training in Transthyretin Cardiac Amyloidosis · NA · recruiting
- NCT06322030 — Weight Loss and ExeRcise for Post-stroke Veterans · NA · recruiting
- NCT04909008 — Exercise Training to Improve Cardiopulmonary Hemodynamics in Heart Failure Patients · NA · suspended
Other recruiting trials for Scapholunate Interosseous Ligament Injury
Currently open trials in the same condition.
- NCT07134452 — Comparison of Strength, Weight Bearing, Proprioception, Reaction Time and Function in Scapholunate Instability · active not recruiting
Other Hacettepe University trials
Trials by the same sponsor.
- NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
- NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
- NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
- NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
- NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06627296 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
- Last refreshed: 12 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06627296.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing